[ Inside the business ]

AXON stock analysis

AXON · Axon Enterprise, Inc.

Ordnance and accessories, (no vehicles/guided missiles). Growing 28%. Keeps 2¢ of every dollar.

Watch: growth that has stopped speeding up.

The future, in 7 questions

Priced in: 2.8× sales in 5 yrs. Evidence: backlog covers it · sales +28% · 2¢ profit/$1 · Counter-drone systems rising.

01 What's priced in?2.8× sales in 5 yrs
Sales now$3.4B
Needed in 5 yrs$9.6B
Backlog$10.2B
02 Is the wave rising?Counter-drone systems · 1.9×
'20'21'22'23'24'2523
#8 of 20 mentioning it
03 Will customers keep buying?Sales +28%, slowing
No customer over 10%
Backlog $10.2B · 3.0× salesPrepaid $742MSales +28%, slowing
04 Is it scarce?No
PricingBacklogPrepaidSell-outTight
05 More profit per sale?Keeps 2¢ per $1, falling
'21'22'23'24'252¢
Before running costs: 61% → 60%
06 Can it fund itself?Pays its own way
05 yrsself-funded
Shares +4.5%/yrDebt $2.9B
07 What could break it?1 to watch
  • Growth peaked

From SEC filings, price and Radar. Not advice.

The record

Early signals

Growth peaked.

Sales growth +34%, +35%, then +28% vs. a year ago.

What could go wrong

Red flags.

It has moved 0.9× the market. In the 2008 crisis it fell 74% while the market fell 51%. Debt is heavy. 2 red flags in its filings.

Speculative check

Not classified.

Not Self-funding because of: debt over 4× operating profit.

What they sell

45% Service.

Service 45% · TASER Devices (Professional) 29% · Platform Solutions 14% · Personal Sensors 12%

Where each dollar goes

2¢ profit.

41¢ to make what it sells, 57¢ on research and overhead, 2¢ left over. Revenue $3.4B in the last 12 months.

Its market

0.3× the economy.

The government expects its industry, fabricated metal product manufacturing, to grow 0.7% a year to 2035, vs. 2.0% for the whole economy.

Market size and share

Your call.

There's no official size for its market. Enter one you trust to see its share, and slide to see what a bigger share would mean.

Life cycle

Growth.

It earns cash, invests heavily, and still raises money to grow.

Earnings quality

Can't score.

Not available: some of the eight inputs aren't in the company's structured filings (common for banks, insurers and companies without a cost of goods line).

Competitive advantage

1 of 10 years.

Returns beat its 10.3% cost of capital in 1 of the last 10 years. Gross margin went from 64% to 60%.

Future bets

23% on research.

$784M a year on R&D. $145M on equipment and buildings.

All figures from Axon Enterprise, Inc.'s SEC filings (EDGAR) unless tagged otherwise. Educational only, not investment advice.